Sensus Healthcare (SRTS) FCF Margin (2017 - 2025)
Sensus Healthcare's (SRTS) quarterly FCF Margin came in at 41.08% in Q4 2025, down 3100.0% year-on-year from 1.37% in Q4 2024, and down 230.75% quarter-over-quarter from 31.42% in Q3 2025.
Sensus Healthcare (SRTS) FCF Margin (2017 - 2025) Analysis & Trends
Sensus Healthcare's FCF Margin history runs 9 years deep, the most recent figure standing at 41.08% for Q4 2025.
- On a quarterly basis, FCF Margin fell 3100.0% year-over-year to 41.08% in Q4 2025; TTM through Dec 2025 was 1.96%, a 461.0% increase from a year earlier, with the FY2025 full-year figure at 1.96%, up 461.0% from the prior year.
- FCF Margin slipped to 41.08% in Q4 2025 per SRTS's latest filing, from 31.42% in the prior quarter.
- Across five years, FCF Margin topped out at 49.92% in Q2 2024 and bottomed at 175.63% in Q1 2023.
- The 5-year median for FCF Margin is 13.44% (2022), against an average of 6.25%.
- Across the five-year window, FCF Margin soared 19219 bps in 2021 and plunged 20502 bps in 2023, its largest moves.
- Year by year, FCF Margin stood at 13.96% in 2021, then slumped by 468 bps to 79.22% in 2022, then soared by 126 bps to 20.57% in 2023, then slumped by 149 bps to 10.08% in 2024, then sank by 308 bps to 41.08% in 2025.
- Per Business Quant, the three latest SRTS FCF Margin figures stand at 41.08% (Q4 2025), 31.42% (Q3 2025), and 42.24% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.08% |
| Sep 30, 2025 | 31.42% |
| Jun 30, 2025 | 42.24% |
| Mar 31, 2025 | -32.17% |
| Dec 31, 2024 | -10.08% |
| Sep 30, 2024 | 45.46% |
| Jun 30, 2024 | 49.92% |
| Mar 31, 2024 | -78.96% |
| Dec 31, 2023 | 20.57% |
| Sep 30, 2023 | 11.06% |
| Jun 30, 2023 | 11.55% |
| Mar 31, 2023 | -175.63% |
| Dec 31, 2022 | -79.22% |
| Sep 30, 2022 | 40.65% |
| Jun 30, 2022 | 15.32% |
| Mar 31, 2022 | 29.39% |
| Dec 31, 2021 | -13.96% |
| Sep 30, 2021 | 22.62% |
| Jun 30, 2021 | 24.88% |
| Mar 31, 2021 | -38.93% |